OTCPK:AMBB.Y

Stock Analysis Report

Executive Summary

Ambu A/S provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally.

Snowflake

Fundamentals

High growth potential with solid track record.


Similar Companies

Share Price & News

How has Ambu's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-3.1%

AMBB.Y

1.9%

US Medical Equipment

0.4%

US Market


1 Year Return

-27.5%

AMBB.Y

15.6%

US Medical Equipment

6.9%

US Market

Return vs Industry: AMBB.Y underperformed the US Medical Equipment industry which returned 15.6% over the past year.

Return vs Market: AMBB.Y underperformed the US Market which returned 6.9% over the past year.


Shareholder returns

AMBB.YIndustryMarket
7 Day-3.1%1.9%0.4%
30 Day-5.3%-1.7%-1.1%
90 Day7.0%-0.03%-0.5%
1 Year-27.4%-27.5%16.5%15.6%9.3%6.9%
3 Yearn/a72.1%66.9%45.8%36.4%
5 Yearn/a125.8%100.8%62.9%45.1%

Price Volatility Vs. Market

How volatile is Ambu's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Ambu undervalued compared to its fair value and its price relative to the market?

49.72x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: AMBB.Y ($16.21) is trading above our estimate of fair value ($14.87)

Significantly Undervalued: AMBB.Y is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AMBB.Y is poor value based on its PE Ratio (49.7x) compared to the Medical Equipment industry average (42.2x).

PE vs Market: AMBB.Y is poor value based on its PE Ratio (49.7x) compared to the US market (17.6x).


Price to Earnings Growth Ratio

Low PEG Ratio: AMBB.Y is poor value based on its PEG Ratio (2.5x)


Price to Book Ratio

PB vs Industry: AMBB.Y is overvalued based on its PB Ratio (11.5x) compared to the US Medical Equipment industry average (3.8x).


Next Steps

Future Growth

How is Ambu forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

20.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMBB.Y's forecast earnings growth (20.2% per year) is above the savings rate (2.7%).

Earnings vs Market: AMBB.Y's earnings (20.2% per year) are forecast to grow faster than the US market (14.6% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMBB.Y's revenue (14.6% per year) is forecast to grow faster than the US market (7.2% per year).

High Growth Revenue: AMBB.Y's revenue (14.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: AMBB.Y's Return on Equity is forecast to be high in 3 years time (21.9%)


Next Steps

Past Performance

How has Ambu performed over the past 5 years?

24.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: AMBB.Y's earnings have grown significantly by 24% per year over the past 5 years.

Accelerating Growth: AMBB.Y's earnings growth over the past year (62%) exceeds its 5-year average (24% per year).

Earnings vs Industry: AMBB.Y earnings growth over the past year (62%) exceeded the Medical Equipment industry 28.2%.


Return on Equity

High ROE: AMBB.Y's Return on Equity (23.1%) is considered high.


Return on Assets

ROA vs Industry: AMBB.Y has a higher Return on Assets than the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: AMBB.Y's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Ambu's financial position?


Financial Position Analysis

Short Term Liabilities: AMBB.Y's short term assets (DKK1.0B) exceeds its short term liabilities (DKK746.0M)

Long Term Liabilities: AMBB.Y's short term assets (1.0B) do not cover its long term liabilities (1.4B)


Debt to Equity History and Analysis

Debt Level: AMBB.Y's debt to equity ratio (46.9%) is considered high

Reducing Debt: AMBB.Y's debt to equity ratio has reduced from 126.4% to 46.9% over the past 5 years.

Debt Coverage: AMBB.Y's debt is well covered by operating cash flow (57.1%).

Interest Coverage: AMBB.Y's interest payments on its debt are well covered by EBIT (24.1x coverage).


Balance Sheet

Inventory Level: AMBB.Y has a low level of unsold assets or inventory.

Debt Coverage by Assets: AMBB.Y's debt is not covered by short term assets (assets are 1x debt).


Next Steps

Dividend

What is Ambu's current dividend yield, its reliability and sustainability?

0.38%

Current Dividend Yield


Dividend Yield vs Market

company0.4%marketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Years0.6%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: AMBB.Y's dividend (0.38%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.45%).

High Dividend: AMBB.Y's dividend (0.38%) is low compared to the top 25% of dividend payers in the US market (3.73%).

Stable Dividend: AMBB.Y is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: AMBB.Y is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: AMBB.Y is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMBB.Y's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Ambu's salary, the management and board of directors tenure and is there insider trading?

5.6yrs

Average management tenure


CEO

Juan-José Gonzalez (46yo)

0.4yrs

Tenure

0

Mr. Juan-José Gonzalez has been Chief Executive Officer of Ambu A/S since May 15, 2019 and also had been its President since 2019 until 2019. He is an engineer and MBA graduate and has held a number of sen ...


Management Age and Tenure

5.6yrs

Average Tenure

55.5yo

Average Age

Experienced Management: AMBB.Y's management team is seasoned and experienced (5.6 years average tenure).


Board Age and Tenure

3.8yrs

Average Tenure

48.5yo

Average Age

Experienced Board: AMBB.Y's board of directors are considered experienced (3.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Anders Williamsson (65yo)

    Managing Director

    • Tenure: 0yrs
  • Chresten Christensen

    Director General of Ambu S.R.L. & Ambu S.L.

    • Tenure: 0yrs
  • Michael Højgaard (55yo)

    CFO, Executive VP of Global Finance

    • Tenure: 6.8yrs
    • Compensation: ø7.70m
  • Steven Block (56yo)

    CEO & President of USA

    • Tenure: 6.5yrs
  • Keith McCallum

    Managing Director of Ambu UK

    • Tenure: 18.6yrs
  • Henrik Ankjær

    Executive Vice President of Global Operations

    • Tenure: 1yrs
  • Johannes Pick

    Managing Director of Ambu GmbH

    • Tenure: 0yrs
  • Måns Barsne

    Executive Vice President of Global Innovation & Chief Innovation Officer

    • Tenure: 4.8yrs
  • Nicolai Thomsen

    IR Manager

    • Tenure: 0yrs
  • Juan-José Gonzalez (46yo)

    Chief Executive Officer

    • Tenure: 0.4yrs

Board Members

  • Jens Bager (60yo)

    Chairman of the Board

    • Tenure: 0yrs
  • Christian Sagild (60yo)

    Director

    • Tenure: 7.8yrs
  • Mikael Worning (57yo)

    Vice Chairman

    • Tenure: 0yrs
  • Henrik Wulff (49yo)

    Director

    • Tenure: 3.8yrs
  • Jakob Kristensen (47yo)

    Employee Representative Director

    • Tenure: 6.8yrs
  • Oliver Johansen (48yo)

    Director

    • Tenure: 3.8yrs
  • Thomas Henriksen (46yo)

    Employee Representative Director

    • Tenure: 2.8yrs
  • Jakob Koch (40yo)

    Employee Representative Director

    • Tenure: 2.8yrs

Company Information

Ambu A/S's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ambu A/S
  • Ticker: AMBB.Y
  • Exchange: OTCPK
  • Founded: 1937
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: ø25.680b
  • Listing Market Cap: ø3.829b
  • Shares outstanding: 245.04m
  • Website: https://www.ambu.com

Number of Employees


Location

  • Ambu A/S
  • Baltorpbakken 13
  • Ballerup
  • Capital Region of Denmark
  • 2750
  • Denmark

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMBU BCPSE (OMX Nordic Exchange Copenhagen)YesClass B SharesDKDKKAug 1992
AMBF.FOTCPK (Pink Sheets LLC)YesClass B SharesUSUSDAug 1992
AMBUBCBATS-CHIXE (BATS 'Chi-X Europe')YesClass B SharesGBDKKAug 1992
0R4LLSE (London Stock Exchange)YesClass B SharesGBDKKAug 1992
AMBB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDJul 2017

Biography

Ambu A/S provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally. The company offers anesthesia produc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/20 00:43
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.